Experience of indinavir/ritonavir 400/100 mg twice-daily highly active antiretroviral therapy-containing regimen in HIV-1-infected patients in Bamako, Mali: the NOGOMA Study.
J Acquir Immune Defic Syndr
; 45(4): 477-9, 2007 Aug 01.
Article
in En
| MEDLINE
| ID: mdl-17622837
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
HIV Protease Inhibitors
/
Indinavir
/
Ritonavir
/
Antiretroviral Therapy, Highly Active
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Africa
Language:
En
Journal:
J Acquir Immune Defic Syndr
Journal subject:
SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS)
Year:
2007
Document type:
Article
Country of publication:
United States